BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 24091297)

  • 41. Thermodynamics of the interaction of human immunoglobulin E with its high-affinity receptor Fc epsilon RI.
    Keown MB; Henry AJ; Ghirlando R; Sutton BJ; Gould HJ
    Biochemistry; 1998 Jun; 37(25):8863-9. PubMed ID: 9636027
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human mast cell line-1 (HMC-1) cells transfected with FcεRIα are sensitive to IgE/antigen-mediated stimulation demonstrating selectivity towards cytokine production.
    Xia YC; Sun S; Kuek LE; Lopata AL; Hulett MD; Mackay GA
    Int Immunopharmacol; 2011 Aug; 11(8):1002-11. PubMed ID: 21356342
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mapping the site of interaction between murine IgE and its high affinity receptor with chimeric Ig.
    Weetall M; Shopes B; Holowka D; Baird B
    J Immunol; 1990 Dec; 145(11):3849-54. PubMed ID: 2147205
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Suppression of mast cell degranulation through a dual-targeting tandem IgE-IgG Fc domain biologic engineered to bind with high affinity to FcγRIIb.
    Cemerski S; Chu SY; Moore GL; Muchhal US; Desjarlais JR; Szymkowski DE
    Immunol Lett; 2012 Mar; 143(1):34-43. PubMed ID: 22305932
    [TBL] [Abstract][Full Text] [Related]  

  • 45. IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site.
    Sandomenico A; Monti SM; Marasco D; Dathan N; Palumbo R; Saviano M; Ruvo M
    Mol Immunol; 2009 Oct; 46(16):3300-9. PubMed ID: 19699527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of total IgE by targeted coengagement of IgE B-cell receptor and FcγRIIb with Fc-engineered antibody.
    Chu SY; Horton HM; Pong E; Leung IW; Chen H; Nguyen DH; Bautista C; Muchhal US; Bernett MJ; Moore GL; Szymkowski DE; Desjarlais JR
    J Allergy Clin Immunol; 2012 Apr; 129(4):1102-15. PubMed ID: 22257644
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction of a monoclonal IgE-specific antibody with cell-surface IgE-Fc epsilon RI: characterization of equilibrium binding and secretory response.
    Posner RG; Paar JM; Licht A; Pecht I; Conrad DH; Hlavacek WS
    Biochemistry; 2004 Sep; 43(35):11352-60. PubMed ID: 15366945
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Redirected cytotoxic effector function. Requirements for expression of chimeric single chain high affinity immunoglobulin e receptors.
    Kershaw MH; Darcy PK; Hulett MD; Hogarth PM; Trapani JA; Smyth MJ
    J Biol Chem; 1996 Aug; 271(35):21214-20. PubMed ID: 8702893
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Structure and dynamics of IgE-receptor interactions: FcεRI and CD23/FcεRII.
    Sutton BJ; Davies AM
    Immunol Rev; 2015 Nov; 268(1):222-35. PubMed ID: 26497523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The intrinsic flexibility of IgE and its role in binding FcepsilonRI.
    Harwood NE; McDonnell JM
    Biomed Pharmacother; 2007 Jan; 61(1):61-7. PubMed ID: 17188833
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Monomeric immunoglobulin E stabilizes FcepsilonRIalpha from the human basophil cell line KU812 by protecting it from natural turnover.
    Jensen BM; Hansen JB; Dissing S; Gerwien J; Skov PS; Poulsen LK
    Clin Exp Allergy; 2003 May; 33(5):655-62. PubMed ID: 12752595
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of an in vitro model system for studying the interaction of Equus caballus IgE with its high-affinity receptor FcɛRI.
    Sabban S; Ye H; Helm B
    Vet Immunol Immunopathol; 2013 May; 153(1-2):10-6. PubMed ID: 23485176
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Chimeric immunoglobulin E reactive with tumor-associated antigen activates human Fc epsilon RI bearing cells.
    Luiten RM; Warnaar SO; Schuurman J; Pasmans SG; Latour S; Daëron M; Fleuren GJ; Litvinov SV
    Hum Antibodies; 1997; 8(4):169-80. PubMed ID: 9395919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Fc receptor (FcR) gamma subunit is essential for IgE-binding activity of cell-surface expressed chimeric receptor molecules constructed from human high-affinity IgE receptor (Fc epsilon RI) alpha and FcR gamma subunits.
    Suzuki K; Hirose T; Matsuda H; Hasegawa S; Okumura K; Ra C
    Mol Immunol; 1998 Apr; 35(5):259-70. PubMed ID: 9747886
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The membrane-proximal part of FcepsilonRIalpha contributes to human IgE and antibody binding--implications for a general structural motif in Fc receptors.
    Nechansky A; Aschauer H; Kricek F
    FEBS Lett; 1998 Dec; 441(2):225-30. PubMed ID: 9883889
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular basis for nonanaphylactogenicity of a monoclonal anti-IgE antibody.
    Rudolf MP; Zuercher AW; Nechansky A; Ruf C; Vogel M; Miescher SM; Stadler BM; Kricek F
    J Immunol; 2000 Jul; 165(2):813-9. PubMed ID: 10878355
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mapping of murine IgE epitopes involved in IgE-Fc epsilon receptor interactions.
    Schwarzbaum S; Nissim A; Alkalay I; Ghozi MC; Schindler DG; Bergman Y; Eshhar Z
    Eur J Immunol; 1989 Jun; 19(6):1015-23. PubMed ID: 2473907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Structural optimization and anti-allergic activity of nucleotide aptamers target to Cε3-Cε4.
    Yang Y; Zhao L; Zhang S; Xu Z; Hao L; Cui Z; Bi K; Zhang Y; Liu Z
    Biochem Pharmacol; 2019 Mar; 161():121-135. PubMed ID: 30653949
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Functional contributions of the FcepsilonRIalpha and FepsilonRIgamma subunit domains in FcepsilonRI-mediated signaling in mast cells.
    Repetto B; Bandara G; Kado-Fong H; Larigan JD; Wiggan GA; Pocius D; Basu M; Gilfillan AM; Kochan JP
    J Immunol; 1996 Jun; 156(12):4876-83. PubMed ID: 8648137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Epitope analysis and primary structures of variable regions of anti-human FcepsilonRI monoclonal antibodies, and expression of the chimeric antibodies fused with human constant regions.
    Takai T; Yuuki T; Iwamoto-Yasue N; Okumura K; Ra C
    Biosci Biotechnol Biochem; 2000 Sep; 64(9):1856-67. PubMed ID: 11055388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.